Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04539938 |
|---|---|
| Brief Title: | A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer (HER2CLIMB-04) |
| First Submitted : | August 31, 2020 |
| First Submitted that Met QC Criteria : | August 31, 2020 |
| First Posted : | September 7, 2020 |
| Last Update Submitted that Met QC Criteria : | March 5, 2024 |
| Last Update Posted : | March 6, 2024 |